McKesson Corporation (LON:0JZU)

Market Cap	73.53B
Revenue (ttm)	275.61B
Net Income (ttm)	2.31B
Shares Out	n/a
EPS (ttm)	18.21
PE Ratio	31.84
Forward PE	20.12
Dividend	2.26 (0.29%)
Ex-Dividend Date	Sep 2, 2025

Volume	307
Average Volume	328
Open	784.94
Previous Close	783.10
Day's Range	777.20 - 791.27
52-Week Range	492.90 - 783.10
Beta	0.51
RSI	65.39
Earnings Date	Nov 5, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JZU

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD